pargyline has been researched along with Cardiac Failure in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sole, MJ | 1 |
| Shum, A | 1 |
| Van Loon, GR | 1 |
| Alousi, AA | 1 |
| Matsumoto, T | 1 |
| Suzuki, O | 1 |
| Furuta, T | 1 |
| Asai, M | 1 |
| Kurokawa, Y | 1 |
| Nimura, Y | 1 |
| Katsumata, Y | 1 |
| Takahashi, I | 1 |
| Vidt, DG | 1 |
4 other studies available for pargyline and Cardiac Failure
| Article | Year |
|---|---|
Serotonin metabolism in the normal and failing hamster heart.
Topics: Animals; Cardiomyopathies; Cricetinae; Dihydroxytryptamines; Female; Heart Failure; Humans; Hydroxyd | 1979 |
Cardiovascular effects of dopamine in the normal and failing heart of experimental animals.
Topics: Animals; Atropine; Blood Pressure; Cricetinae; Dogs; Dopamine; Dopamine Antagonists; Female; Guinea | 1975 |
A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate.
Topics: Heart Failure; Humans; Hydrogen-Ion Concentration; Kinetics; Kynuramine; Liver Diseases; Monoamine O | 1985 |
An approach to the medical treatment of hypertension in the aged.
Topics: Age Factors; Aged; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Diuretics; | 1969 |